Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Inotiv Inc. | 3 | 1 | 1 | 0 | €1.69 | €10.66 | 530.870% |
| Illumina Inc. | 19 | 4 | 2 | 0 | €101.00 | €169.78 | 68.096% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.92 | €3.00 | 56.495% |
| NanoVibronix Inc. | 0 | 1 | 0 | 0 | €0.67 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.98 | €6.49 | 561.651% |
| Ionis Pharmaceuticals Inc. | 19 | 5 | 2 | 0 | €34.33 | €56.86 | 65.634% |
| Ocuphire Pharma Inc. | 6 | 1 | 1 | 0 | €1.55 | €18.37 | 1084.903% |
| Accelerate Diagnostics Inc. | 1 | 1 | 0 | 0 | €0.88 | - | - |
| T2 Biosystems Inc. | 0 | 11 | 0 | 0 | €0.16 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.35 | - | - |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €1.00 | - | - |
| Acadia Pharmaceuticals | 28 | 1 | 6 | 0 | €13.64 | €31.78 | 133.021% |
| Revance Therapeutics Inc. | 1 | 1 | 0 | 1 | €2.86 | €6.00 | 109.790% |
| Cardiff Oncology Inc. | 2 | 4 | 1 | 1 | €3.35 | €5.00 | 49.254% |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 1 | €3.62 | €8.27 | 128.537% |
| Moleculin Biotech Inc | 3 | 26 | 0 | 1 | €0.41 | €18.42 | 4393.659% |
| Trevena Inc. | 2 | 14 | 1 | 1 | €0.35 | €6.48 | 1778.841% |
| Sage Therapeutics Inc. | 5 | 3 | 1 | 1 | €11.04 | €26.71 | 141.982% |
| Cytomx Therapeutics Inc | 1 | 1 | 1 | 1 | €1.77 | €50.00 | 2721.670% |
| Savara Inc. | 1 | 1 | 0 | 1 | €4.62 | €8.00 | 73.160% |
| Minerva Neurosciences Inc. | 0 | 6 | 0 | 1 | €2.26 | - | - |
| BioLase Inc. | 0 | 8 | 0 | 2 | €0.067 | - | - |
| Organovo Holdings Inc. | 0 | 7 | 0 | 2 | €0.98 | €3.00 | 204.878% |
| Integra LifeSciences Holdings Corp | 3 | 5 | 0 | 2 | €25.20 | €34.68 | 37.613% |
| Arca Biopharma | 0 | 22 | 0 | 2 | €2.98 | - | - |